Atlas Trials

Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis

Clinical trial NCT06818279 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06818279
Sponsor
Institute of Liver and Biliary Sciences, India
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Portal Vein ThrombosisLiver Cirrhosis
Start date
2025-01-31
Primary completion
2026-01-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.